Scarica l'app Stockscreener
302.28
1.26%
-3.85
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$306.13
Aprire:
$303.8
Volume 24 ore:
1.14M
Relative Volume:
0.65
Capitalizzazione di mercato:
$58.81B
Reddito:
$328.68B
Utile/perdita netta:
$2.55B
Rapporto P/E:
23.19
EPS:
13.0349
Flusso di cassa netto:
$1.56B
1 W Prestazione:
-0.72%
1M Prestazione:
+7.32%
6M Prestazione:
-13.62%
1 anno Prestazione:
+1.76%
Intervallo 1D:
$299.84
$304.26
Intervallo di 1 settimana:
$299.82
$310.45
Portata 52W:
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
Nome
Cencora Inc
Settore
Industria
Telefono
610-727-7000
Indirizzo
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
302.28 | 59.56B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
803.37 | 95.10B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
230.11 | 54.72B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
86.91 | 9.77B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.52 | 1.27B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-29 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-09-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2023-01-31 | Ripresa | Evercore ISI | Outperform |
| 2022-10-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Ripresa | Evercore ISI | In-line |
| 2021-02-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-01-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Iniziato | Mizuho | Neutral |
| 2020-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Iniziato | Barclays | Underweight |
| 2020-06-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Ripresa | Credit Suisse | Outperform |
| 2020-04-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-02-11 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-07-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Iniziato | Guggenheim | Buy |
| 2019-04-10 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-10 | Downgrade | Jefferies | Buy → Hold |
| 2018-10-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Iniziato | Berenberg | Buy |
| 2018-07-17 | Ripresa | Stifel | Hold |
| 2018-04-09 | Iniziato | MoffettNathanson | Buy |
| 2018-03-12 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Iniziato | JP Morgan | Neutral |
| 2017-09-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Cencora Inc Borsa (COR) Ultime notizie
Cencora stock reflects steady growth as healthcare distribution evolves - Ad-hoc-news.de
Cencora (COR) Following Soft Earnings Is The Stock Starting To Look Undervalued - simplywall.st
ABC4987224 Bond Risk Profile - TradingView
Cencora : World Courier Expands Cold Chain Capabilities | Cencora - marketscreener.com
ABC4987224 Bond Profile — Key Metrics - TradingView
Cencora stock reflects steady growth in pharmaceutical distribution and services - Ad-hoc-news.de
Cencora stock reflects steady healthcare distribution role in a complex market - Ad-hoc-news.de
Cencora (COR) Stock Still Looks Undervalued On Cash Flow And Earnings - simplywall.st
ETFs Investing in Cencora, Inc. Stocks - TradingView
Deals tracker: IKS Health acquires TruBridge in $557M deal - Modern Healthcare
Cencora stock trades steadily as healthcare distribution scale supports long-term growth - ad-hoc-news.de
Cencora Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Pricing Headwinds and Industry Trends Cut Into Cencora's 2026 Sales, but Fundamentals Remain Strong - Morningstar
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Centene Corp navigates Medicaid shifts. Investors track managed care margins - Ad-hoc-news.de
Cencora Inc. focuses on pharmaceutical distribution scale as investors eye healthcare demand - ad-hoc-news.de
AQR Managed Futures Strategy Fund's Cencora Inc(COR) Holding History - GuruFocus
Form 4 Cencora Inc For: 7 July By Investing.com - Investing.com Nigeria
Cencora (COR) EVP adds common stock through employee purchase plan - Stock Titan
Cencora (COR) EVP acquires stock through Employee Stock Purchase Plan - Stock Titan
Cencora Inc. focuses on distribution strength as investors weigh long-term growth - ad-hoc-news.de
Centene Corp evaluates its strategy as US health coverage needs evolve - AD HOC NEWS
Cencora Inc. highlights its role in pharmaceutical distribution. Investors watch the company’s evo - AD HOC NEWS
Steve Collis: Pharmaceutical Distribution Leader and Former Chairman, President, and CEO of Cencora - BBN Times
Enterprise value to revenue forward of Cencora, Inc. – NYSE:COR - TradingView
Enterprise value to EBITDA forward of Cencora, Inc. – NYSE:COR - TradingView
3 Defensive Stocks Investors Are Watching As Markets Turn Cautious - Sahm
Cencora (COR) Could Be 15% Undervalued As Earnings Date Nears - simplywall.st
Cencora announces Q3 FY26 earnings release date - scanx.trade
Press Release: Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release - Moomoo
Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release - marketscreener.com
Cencora Inc. focuses on pharmaceutical distribution and healthcare services - AD HOC NEWS
Cencora lines up Aug. 5 earnings call before NYSE opens - Stock Titan
Cencora CubixxCT from Cencora Inc.cold-chain automation for hospital pharmacies - AD HOC NEWS
Form 4 Cencora Inc For: 30 June By Investing.com - Investing.com Canada
Cencora (COR) CFO receives 21,304 restricted stock units vesting through 2029 - Stock Titan
Cencora (COR) CFO files Form 3 showing small direct and trust holdings - Stock Titan
Cencora Pick of the Week at Smart Insider Following Chairman's Share Purchase - marketscreener.com
Cencora reports steady business model, shares anchored in US healthcare distribution - AD HOC NEWS
Cencora, Inc. (COR) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
The Velocity patient support solution from Cencora Inc.integrated care for specialty therapies - AD HOC NEWS
Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch
Cencora operations and strategy, shares reflect ongoing integration of COR acquisition - AD HOC NEWS
Cencora (COR) Stock After Recent Pullback And DCF Valuation Gap - Yahoo Finance
Nucleus inventory solution from Cencora Inc.modular cabinets and tighter control for specialty pr - AD HOC NEWS
Cencora (COR) Launches Nucleus Pilot As Verizon Executive Joins As CHRO - Yahoo Finance
Cencora revises 2026 outlook, shares underpinned by buyback and analyst support - Ad-hoc-news.de
Knights of Columbus Large Cap Value Fund's Cencora Inc(COR) Holding History - GuruFocus
Cencora, S&P 500 peer under pressure, shares lag broader healthcare distributors - Ad-hoc-news.de
3 Big Reasons to Love Cencora (COR) - Yahoo Finance
Cencora (COR) Stock After Healthcare Supply Chain Reassessment Is The Market Overreacting - simplywall.st
Cencora Inc Azioni (COR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.52%
1.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):